A Step-by-Step Practical Approach to Imaging Diagnosis and Interventional Radiologic Therapy in Vascular Malformations

ABSTRACT

Within vascular anomalies, vascular malformations are those present at birth that grow with the patient and exhibit abnormal dilated vascular channels lined by mature endothelium. Vascular tumors, the other group of vascular anomalies, demonstrate endothelial hypercellularity. Vascular malformations are further divided into low-flow varieties (capillary, venous, and lymphatic malformations) and high-flow varieties (arteriovenous malformation and fistula). All malformations exhibit a predictable group of clinical patterns that vary in severity and rate of progression. The interventional radiologist must incorporate this clinical data with characteristic ultrasound and magnetic resonance findings to arrive at a diagnosis. One must then decide in a multidisciplinary fashion, based on objective clinical criteria and image-based morphology, if the patent is a candidate for intervention. Sclerotherapy is a technique used to treat vascular malformations whereby an endothelial-cidal agent is introduced into the endoluminal compartment to initiate vascular closure. The high flow rate of an arteriovenous malformation requires the incorporation of superselective transarterial, direct, and transvenous access with flow reduction techniques to deliver adequate dose of sclerosant and embolic to the nidus. Satisfactory outcomes are seen in over half of all malformations patients. Similar treatment-related complications are seen between malformations but are lowest in lymphatic and highest in arteriovenous malformations.

KEYWORDS

Vascular malformation - vascular anomalies - sclerotherapy - embolization - venous malformation - lymphatic malformation - arteriovenous malformation - radiology - hemangioma - classification

REFERENCES

• 1 Lee B B, Bergan J J. Advanced management of congenital vascular malformations: a multidisciplinary approach.  Cardiovasc Surg. 2002;  10 523-533
• 2 Legiehn G M, Heran M K. Venous malformations: classification, development, diagnosis, and interventional radiologic management.  Radiol Clin North Am. 2008;  46 545-597 , vi
• 3 Nagy M, Brodsky L. Multidisciplinary approach to management of hemangiomas and vascular malformations.  Facial Plast Surg Clin North Am. 2001;  9 551-559
• 4 Lee B B. New approaches to the treatment of congenital vascular malformations (CVMs)—a single centre experience.  Eur J Vasc Endovasc Surg. 2005;  30 184-197
• 5 Donnelly L F, Adams D M, Bisset III G S. Vascular malformations and hemangiomas: a practical approach in a multidisciplinary clinic.  AJR Am J Roentgenol. 2000;  174 597-608
• 6 Mulliken J B, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics.  Plast Reconstr Surg. 1982;  69 412-422
• 7 Mulliken J B, Zetter B R, Folkman J. In vitro characteristics of endothelium from hemangiomas and vascular malformations.  Surgery. 1982;  92 348-353
• 8 Jackson I T, Carreño R, Potparic Z, Hussain K. Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment.  Plast Reconstr Surg. 1993;  91 1216-1230
• 9 Fishman S J, Mulliken J B. Hemangiomas and vascular malformations of infancy and childhood.  Pediatr Clin North Am. 1993;  40 1177-1200
• 10 Kilpatrick S E. Diagnostic Musculoskeletal Surgical Pathology: Clinicoradiologic and Cytologic Correlations. Philadelphia; Saunders 2004
• 11 North P E, Mihm Jr M C. Histopathological diagnosis of infantile hemangiomas and vascular malformations.  Facial Plast Surg Clin North Am. 2001;  9 505-524
• 12 Hein K D, Mulliken J B, Kozakewich H P, Upton J, Burrows P E. Venous malformations of skeletal muscle.  Plast Reconstr Surg. 2002;  110 1625-1635
• 13 Mazoyer E, Enjolras O, Laurian C, Houdart E, Drouet L. Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome.  Clin Lab Haematol. 2002;  24 243-251
• 14 Dompmartin A, Acher A, Thibon P et al.. Association of localized intravascular coagulopathy with venous malformations.  Arch Dermatol. 2008;  144 873-877
• 15 Clearkin K P, Enzinger F M. Intravascular papillary endothelial hyperplasia.  Arch Pathol Lab Med. 1976;  100 441-444
• 16 Legiehn G M, Heran M K. Classification, diagnosis, and interventional radiologic management of vascular malformations.  Orthop Clin North Am. 2006;  37 435-474 vii-viii
• 17 Boyd J B, Mulliken J B, Kaban L B, Upton III J, Murray J E. Skeletal changes associated with vascular malformations.  Plast Reconstr Surg. 1984;  74 789-797
• 18 Savader S J, Savader B L, Otero R R. Intraosseous arteriovenous malformations mimicking malignant disease.  Acta Radiol. 1988;  29 109-114
• 19 Enjolras O, Ciabrini D, Mazoyer E, Laurian C, Herbreteau D. Extensive pure venous malformations in the upper or lower limb: a review of 27 cases.  J Am Acad Dermatol. 1997;  36(2 Pt 1) 219-225
• 20 Garzon M C, Huang J T, Enjolras O, Frieden I J. Vascular malformations: Part I.  J Am Acad Dermatol. 2007;  56 353-370 quiz 371-374
• 21 Dubois J, Soulez G, Oliva V L, Berthiaume M J, Lapierre C, Therasse E. Soft-tissue venous malformations in adult patients: imaging and therapeutic issues.  Radiographics. 2001;  21 1519-1531
• 22 Dubois J, Garel L. Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group.  Pediatr Radiol. 1999;  29 879-893
• 23 Nicolaides A N, Breddin H K, Carpenter P European Genetics Foundation et al. Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence.  Int Angiol. 2005;  24 1-26
• 24 Abernethy L J. Classification and imaging of vascular malformations in children.  Eur Radiol. 2003;  13 2483-2497
• 25 Alqahtani A, Nguyen L T, Flageole H, Shaw K, Laberge J M. 25 years' experience with lymphangiomas in children.  J Pediatr Surg. 1999;  34 1164-1168
• 26 Emery P J, Bailey C M, Evans J N. Cystic hygroma of the head and neck. A review of 37 cases.  J Laryngol Otol. 1984;  98 613-619
• 27 Buckmiller L M. Update on hemangiomas and vascular malformations.  Curr Opin Otolaryngol Head Neck Surg. 2004;  12 476-487
• 28 Frieden I, Enjolras O, Esterly N. Vascular birthmarks, other abnormalities of blood vessels and lymphatics. In: Schachner LA, Hansen RC Pediatric Dermatology. 3rd ed. New York; Mosby 2003
• 29 Kohout M P, Hansen M, Pribaz J J, Mulliken J B. Arteriovenous malformations of the head and neck: natural history and management.  Plast Reconstr Surg. 1998;  102 643-654
• 30 Paltiel H J, Burrows P E, Kozakewich H P, Zurakowski D, Mulliken J B. Soft-tissue vascular anomalies: utility of US for diagnosis.  Radiology. 2000;  214 747-754
• 31 Trop I, Dubois J, Guibaud L et al.. Soft-tissue venous malformations in pediatric and young adult patients: diagnosis with Doppler US.  Radiology. 1999;  212 841-845
• 32 Sintzoff Jr S A, Gillard I, Van Gansbeke D, Gevenois P A, Salmon I, Struyven J. Ultrasound evaluation of soft tissue tumors.  J Belge Radiol. 1992;  75 276-280
• 33 Konez O, Burrows P E. Magnetic resonance of vascular anomalies.  Magn Reson Imaging Clin N Am. 2002;  10 363-388 vii
• 34 Redondo P. [Vascular malformations (II). Diagnosis, pathology and treatment].  Actas Dermosifiliogr. 2007;  98 219-235
• 35 Moukaddam H, Pollak J, Haims A H. MRI characteristics and classification of peripheral vascular malformations and tumors.  Skeletal Radiol. 2009;  38 535-547
• 36 Fayad L M, Fayad L, Hazirolan T, Bluemke D, Mitchell S. Vascular malformations in the extremities: emphasis on MR imaging features that guide treatment options.  Skeletal Radiol. 2006;  35 127-137
• 37 Meyer J S, Hoffer F A, Barnes P D, Mulliken J B. Biological classification of soft-tissue vascular anomalies: MR correlation.  AJR Am J Roentgenol. 1991;  157 559-564
• 38 Vilanova J C, Barceló J, Smirniotopoulos J G et al.. Hemangioma from head to toe: MR imaging with pathologic correlation.  Radiographics. 2004;  24 367-385
• 39 Ohgiya Y, Hashimoto T, Gokan T et al.. Dynamic MRI for distinguishing high-flow from low-flow peripheral vascular malformations.  AJR Am J Roentgenol. 2005;  185 1131-1137
• 40 van Rijswijk C S, van der Linden E, van der Woude H J, van Baalen J M, Bloem J L. Value of dynamic contrast-enhanced MR imaging in diagnosing and classifying peripheral vascular malformations.  AJR Am J Roentgenol. 2002;  178 1181-1187
• 41 Kern S, Niemeyer C, Darge K, Merz C, Laubenberger J, Uhl M. Differentiation of vascular birthmarks by MR imaging. An investigation of hemangiomas, venous and lymphatic malformations.  Acta Radiol. 2000;  41 453-457
• 42 Rak K M, Yakes W F, Ray R L et al.. MR imaging of symptomatic peripheral vascular malformations.  AJR Am J Roentgenol. 1992;  159 107-112
• 43 Dobson M J, Hartley R W, Ashleigh R, Watson Y, Hawnaur J M. MR angiography and MR imaging of symptomatic vascular malformations.  Clin Radiol. 1997;  52 595-602
• 44 Gulati M S, Paul S B, Batra A, Sarma D, Dadhwal V, Nath J. Uterine arteriovenous malformations: the role of intravenous “dual-phase” CT angiography.  Clin Imaging. 2000;  24 10-14
• 45 Villavicencio J L. Primum non nocere: is it always true? The use of absolute ethanol in the management of congenital vascular malformations.  J Vasc Surg. 2001;  33 904-906
• 46 Rautio R, Saarinen J, Laranne J, Salenius J P, Keski-Nisula L. Endovascular treatment of venous malformations in extremities: results of sclerotherapy and the quality of life after treatment.  Acta Radiol. 2004;  45 397-403
• 47 Rinker B, Karp N S, Margiotta M, Blei F, Rosen R, Rofsky N M. The role of magnetic resonance imaging in the management of vascular malformations of the trunk and extremities.  Plast Reconstr Surg. 2003;  112 504-510
• 48 Do Y S, Yakes W F, Shin S W et al.. Ethanol embolization of arteriovenous malformations: interim results.  Radiology. 2005;  235 674-682
• 49 Yakes W F, Rossi P, Odink H. How I do it. Arteriovenous malformation management.  Cardiovasc Intervent Radiol. 1996;  19 65-71
• 50 Dubois J M, Sebag G H, De Prost Y, Teillac D, Chretien B, Brunelle F O. Soft-tissue venous malformations in children: percutaneous sclerotherapy with Ethibloc.  Radiology. 1991;  180 195-198
• 51 Puig S, Aref H, Chigot V, Bonin B, Brunelle F. Classification of venous malformations in children and implications for sclerotherapy.  Pediatr Radiol. 2003;  33 99-103
• 52 Puig S, Casati B, Staudenherz A, Paya K. Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy.  Eur J Radiol. 2005;  53 35-45
• 53 Cabrera J, Cabrera Jr J J, Garcia-Olmedo M A, Redondo P. Treatment of venous malformations with sclerosant in microfoam form.  Arch Dermatol. 2003;  139 1409-1416
• 54 Mimura H, Kanazawa S, Yasui K et al.. Percutaneous sclerotherapy for venous malformations using polidocanol under fluoroscopy.  Acta Med Okayama. 2003;  57 227-234
• 55 Tan K T, Kirby J, Rajan D K, Hayeems E, Beecroft J R, Simons M E. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience.  J Vasc Interv Radiol. 2007;  18 343-351
• 56 de Lorimier A A. Sclerotherapy for venous malformations.  J Pediatr Surg. 1995;  30 188-193 discussion 194
• 57 Hyodoh H, Hori M, Akiba H, Tamakawa M, Hyodoh K, Hareyama M. Peripheral vascular malformations: imaging, treatment approaches, and therapeutic issues.  Radiographics. 2005;  25(25 Suppl 1) S159-S171
• 58 O'Donovan J C, Donaldson J S, Morello F P, Pensler J M, Vogelzang R L, Bauer B. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate.  AJR Am J Roentgenol. 1997;  169 723-729
• 59 Pascarella L, Bergan J J, Yamada C, Mekenas L. Venous angiomata: treatment with sclerosant foam.  Ann Vasc Surg. 2005;  19 457-464
• 60 Donnelly L F, Bisset III G S, Adams D M. Marked acute tissue swelling following percutaneous sclerosis of low-flow vascular malformations: a predictor of both prolonged recovery and therapeutic effect.  Pediatr Radiol. 2000;  30 415-419
• 61 Yamaki T, Nozaki M, Sasaki K. Color duplex-guided sclerotherapy for the treatment of venous malformations.  Dermatol Surg. 2000;  26 323-328
• 62 Shin B S, Do Y S, Lee B B et al.. Multistage ethanol sclerotherapy of soft-tissue arteriovenous malformations: effect on pulmonary arterial pressure.  Radiology. 2005;  235 1072-1077
• 63 Yakes W F, Haas D K, Parker S H et al.. Symptomatic vascular malformations: ethanol embolotherapy.  Radiology. 1989;  170(3 Pt 2) 1059-1066
• 64 Yakes W F, Krauth L, Ecklund J et al.. Ethanol endovascular management of brain arteriovenous malformations: initial results.  Neurosurgery. 1997;  40 1145-1152 discussion 1152-1154
• 65 Choi Y H, Han M H, O-Ki K, Cha S H, Chang K H. Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate.  J Vasc Interv Radiol. 2002;  13 475-482
• 66 Behnia R. Systemic effects of absolute alcohol embolization in a patient with a congenital arteriovenous malformation of the lower extremity.  Anesth Analg. 1995;  80 415-417
• 67 Garel L, Mareschal J L, Gagnadoux M F, Pariente D, Guilbert M, Sauvegrain J. Fatal outcome after ethanol renal ablation in child with end-stage kidneys.  AJR Am J Roentgenol. 1986;  146 593-594
• 68 Mason K P, Michna E, Zurakowski D, Koka B V, Burrows P E. Serum ethanol levels in children and adults after ethanol embolization or sclerotherapy for vascular anomalies.  Radiology. 2000;  217 127-132
• 69 Stefanutto T B, Halbach V. Bronchospasm precipitated by ethanol injection in arteriovenous malformation.  AJNR Am J Neuroradiol. 2003;  24 2050-2051
• 70 Yakes W F, Baker R. Cardiopulmonary collapse: a sequelae of ethanol embolotherapy. Paper presented at: 79th Scientific Assembly and Annual Meeting of the Radiological Society of North America 1993 Chicago, IL;
• 71 Siniluoto T M, Svendsen P A, Wikholm G M, Fogdestam I, Edström S. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol).  Scand J Plast Reconstr Surg Hand Surg. 1997;  31 145-150
• 72 Guex J J. Indications for the sclerosing agent polidocanol (aetoxisclerol dexo, aethoxisklerol kreussler).  J Dermatol Surg Oncol. 1993;  19 959-961
• 73 Jain R, Bandhu S, Sawhney S, Mittal R. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations.  J Clin Ultrasound. 2002;  30 416-423
• 74 Cacciola E, Giustolisi R, Musso R et al.. Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: possible additional mechanism of adverse reaction during sclerotherapy.  J Lab Clin Med. 1987;  109 225-226
• 75 Marrocco-Trischitta M M, Guerrini P, Abeni D, Stillo F. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation.  Dermatol Surg. 2002;  28 153-155
• 76 Nitecki S, Bass A. Ultrasound-guided foam sclerotherapy in patients with Klippel-Trenaunay syndrome.  Isr Med Assoc J. 2007;  9 72-75
• 77 Suzuki N, Nakao A, Nonami T, Takagi H. Experimental study on the effects of sclerosants for esophageal varices on blood coagulation, fibrinolysis and systemic hemodynamics.  Gastroenterol Jpn. 1992;  27 309-316
• 78 Liu Y, Liu D, Wang Y, Zhang W, Zhao F. Clinical study of sclerotherapy of maxillofacial venous malformation using absolute ethanol and pingyangmycin.  J Oral Maxillofac Surg. 2009;  67 98-104
• 79 Muir T, Kirsten M, Fourie P, Dippenaar N, Ionescu G O. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations.  Pediatr Surg Int. 2004;  19 766-773
• 80 Yang Y, Sun M, Hou R et al.. Preliminary study of fibrin glue combined with pingyangmycin for the treatment of venous malformations in the oral and maxillofacial region.  J Oral Maxillofac Surg. 2008;  66 2219-2225
• 81 Zhi K, Wen Y, Li L, Ren W. The role of intralesional Pingyangmycin in the treatment of venous malformation of facial and maxillary region.  Int J Pediatr Otorhinolaryngol. 2008;  72 593-597
• 82 Chen W L, Yang Z H, Bai Z B, Wang Y Y, Huang Z Q, Wang Y J. A pilot study on combination compartmentalisation and sclerotherapy for the treatment of massive venous malformations of the face and neck.  J Plast Reconstr Aesthet Surg. 2008;  61 1486-1492
• 83 Mathur N N, Rana I, Bothra R, Dhawan R, Kathuria G, Pradhan T. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck.  Int J Pediatr Otorhinolaryngol. 2005;  69 75-80
• 84 Jin Y, Lin X, Li W, Hu X, Ma G, Wang W. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.  J Vasc Surg. 2008;  47 1292-1299
• 85 Sung M W, Chang S O, Choi J H, Kim J Y. Bleomycin sclerotherapy in patients with congenital lymphatic malformation in the head and neck.  Am J Otolaryngol. 1995;  16 236-241
• 86 Bechard D E, Fairman R P, DeBlois G G, Via C T. Fatal pulmonary fibrosis from low-dose bleomycin therapy.  South Med J. 1987;  80 646-649
• 87 Okada A, Kubota A, Fukuzawa M, Imura K, Kamata S. Injection of bleomycin as a primary therapy of cystic lymphangioma.  J Pediatr Surg. 1992;  27 440-443
• 88 Gabal A M. Percutaneous technique for sclerotherapy of vertebral hemangioma compressing spinal cord.  Cardiovasc Intervent Radiol. 2002;  25 494-500
• 89 Johann A C, Aguiar M C, do Carmo M A, Gomez R S, Castro W H, Mesquita R A. Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: an open clinical trial with 30 lesions.  Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;  100 579-584
• 90 Lewin J S, Merkle E M, Duerk J L, Tarr R W. Low-flow vascular malformations in the head and neck: safety and feasibility of MR imaging-guided percutaneous sclerotherapy—preliminary experience with 14 procedures in three patients.  Radiology. 1999;  211 566-570
• 91 Górriz E, Carreira J M, Reyes R et al.. Intramuscular low flow vascular malformations: treatment by means of direct percutaneous embolization.  Eur J Radiol. 1998;  27 161-165
• 92 Kühne D, Helmke K. Embolization with “Ethibloc” of vascular tumors and arteriovenous malformations in the head and neck.  Neuroradiology. 1982;  23 253-258
• 93 Riche M C, Hadjean E, Tran-Ba-Huy P, Merland J J. The treatment of capillary-venous malformations using a new fibrosing agent.  Plast Reconstr Surg. 1983;  71 607-614
• 94 Deveikis J P. Percutaneous ethanol sclerotherapy for vascular malformations in the head and neck.  Arch Facial Plast Surg. 2005;  7 322-325
• 95 Suh J S, Shin K H, Na J B, Won J Y, Hahn S B. Venous malformations: sclerotherapy with a mixture of ethanol and lipiodol.  Cardiovasc Intervent Radiol. 1997;  20 268-273
• 96 Puig S, Aref H, Brunelle F. Double-needle sclerotherapy of lymphangiomas and venous angiomas in children: a simple technique to prevent complications.  AJR Am J Roentgenol. 2003;  180 1399-1401
• 97 Cabrera Garrido J R, Cabrera Garcia-Olmedo J R, Garcia-Olmedo Dominquez M A. Elargissement des limites de la sclerotherapie: nouveaux produits sclerosants.  Phlebologie. 1997;  50 351-353
• 98 Tessari L. Nouvelle technique d'obtention de la sclero-mousse.  Phlebologie. 2000;  53 129
• 99 Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications.  Dermatol Surg. 2002;  28 11-15
• 100 Hamel-Desnos C, Desnos P, Wollmann J C, Ouvry P, Mako S, Allaert F A. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.  Dermatol Surg. 2003;  29 1170-1175 discussion 1175
• 101 Boll D T, Merkle E M, Lewin J S. Low-flow vascular malformations: MR-guided percutaneous sclerotherapy in qualitative and quantitative assessment of therapy and outcome.  Radiology. 2004;  233 376-384
• 102 Hayashi N, Masumoto T, Okubo T et al.. Hemangiomas in the face and extremities: MR-guided sclerotherapy—optimization with monitoring of signal intensity changes in vivo.  Radiology. 2003;  226 567-572
• 103 Lee C H, Chen S G. Direct percutaneous ethanol instillation for treatment of venous malformation in the face and neck.  Br J Plast Surg. 2005;  58 1073-1078
• 104 Woods J E. Extended use of sodium tetradecyl sulfate in treatment of hemangiomas and other related conditions.  Plast Reconstr Surg. 1987;  79 542-549
• 105 Bai Y, Jia J, Huang X X, Alsharif M J, Zhao J H, Zhao Y F. Sclerotherapy of microcystic lymphatic malformations in oral and facial regions.  J Oral Maxillofac Surg. 2009;  67 251-256
• 106 Dubois J, Garel L, Abela A, Laberge L, Yazbeck S. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein.  Radiology. 1997;  204 651-654
• 107 Giguère C M, Bauman N M, Sato Y et al.. Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial.  Arch Otolaryngol Head Neck Surg. 2002;  128 1137-1144
• 108 Goyal M, Mishra N K, Sharma A, Gaikwad S B, Mohanty B K, Sharma A. Alcohol ablation of symptomatic vertebral hemangiomas.  AJNR Am J Neuroradiol. 1999;  20 1091-1096
• 109 Laranne J, Keski-Nisula L, Rautio R, Rautiainen M, Airaksinen M. OK-432 (Picibanil) therapy for lymphangiomas in children.  Eur Arch Otorhinolaryngol. 2002;  259 274-278
• 110 Herbreteau D, Riche M C, Enjolras O et al.. Percutaneous embolization with Ethibloc of lymphatic cystic malformations with a review of the experience in 70 patients.  Int Angiol. 1993;  12 34-39
• 111 Molitch H I, Unger E C, Witte C L, vanSonnenberg E. Percutaneous sclerotherapy of lymphangiomas.  Radiology. 1995;  194 343-347
• 112 Rautio R, Keski-Nisula L, Laranne J, Laasonen E. Treatment of lymphangiomas with OK-432 (Picibanil).  Cardiovasc Intervent Radiol. 2003;  26 31-36
• 113 Shankar K R, Roche C J, Carty H M, Turnock R R. Cystic retroperitoneal lymphangioma: treatment by image-guided percutaneous catheter drainage and sclerotherapy.  Eur Radiol. 2001;  11 1021-1023
• 114 Ogita S, Tsuto T, Tokiwa K, Takahashi T. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children.  Br J Surg. 1987;  74 690-691
• 115 Sung M W, Lee D W, Kim D Y et al.. Sclerotherapy with picibanil (OK-432) for congenital lymphatic malformation in the head and neck.  Laryngoscope. 2001;  111 1430-1433
• 116 Uchida K, Inoue M, Araki T, Miki C, Kusunoki M. Huge scrotal, flank, and retroperitoneal lymphangioma successfully treated by OK-432 sclerotherapy.  Urology. 2002;  60 1112
• 117 Luzzatto C, Midrio P, Tchaprassian Z, Guglielmi M. Sclerosing treatment of lymphangiomas with OK-432.  Arch Dis Child. 2000;  82 316-318
• 118 Greinwald Jr J H, Burke D K, Sato Y et al.. Treatment of lymphangiomas in children: an update of Picibanil (OK-432) sclerotherapy.  Otolaryngol Head Neck Surg. 1999;  121 381-387
• 119 Smith R J, Burke D K, Sato Y, Poust R I, Kimura K, Bauman N M. OK-432 therapy for lymphangiomas.  Arch Otolaryngol Head Neck Surg. 1996;  122 1195-1199
• 120 Mikhail M, Kennedy R, Cramer B, Smith T. Sclerosing of recurrent lymphangioma using OK-432.  J Pediatr Surg. 1995;  30 1159-1160
• 121 Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. OK-432 therapy in 64 patients with lymphangioma.  J Pediatr Surg. 1994;  29 784-785
• 122 Duman L, Karnak I, Akinci D, Tanyel F C. Extensive cervical-mediastinal cystic lymphatic malformation treated with sclerotherapy in a child with Klippel-Trenaunay syndrome.  J Pediatr Surg. 2006;  41 e21-e24
• 123 Baskin D, Tander B, Bankaoğlu M. Local bleomycin injection in the treatment of lymphangioma.  Eur J Pediatr Surg. 2005;  15 383-386
• 124 Mabeta P, Ionescu G O, Muir T et al.. Bleomycin levels in patients undergoing intralesional bleomycin treatment for lymphatic malformation. Paper presented at: 15th Congress of the International Society for the Study of Vascular Anomalies 2004 Wellington, New Zealand;
• 125 Zhong P Q, Zhi F X, Li R, Xue J L, Shu G Y. Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma.  Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;  86 139-144
• 126 Orford J, Barker A, Thonell S, King P, Murphy J. Bleomycin therapy for cystic hygroma.  J Pediatr Surg. 1995;  30 1282-1287
• 127 Tanaka K, Inomata Y, Utsunomiya H et al.. Sclerosing therapy with bleomycin emulsion for lymphangioma in children.  Pediatr Surg Int. 1990;  5 270-273
• 128 Tanigawa N, Shimomatsuya T, Takahashi K et al.. Treatment of cystic hygroma and lymphangioma with the use of bleomycin fat emulsion.  Cancer. 1987;  60 741-749
• 129 Yura J, Hashimoto T, Tsuruga N, Shibata K. Bleomycin treatment for cystic hygroma in children.  Nippon Geka Hokan. 1977;  46 607-614
• 130 Cordes B M, Seidel F G, Sulek M, Giannoni C M, Friedman E M. Doxycycline sclerotherapy as the primary treatment for head and neck lymphatic malformations.  Otolaryngol Head Neck Surg. 2007;  137 962-964
• 131 Shiels II W E, Kenney B D, Caniano D A, Besner G E. Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities.  J Pediatr Surg. 2008;  43 136-139 discussion 140
• 132 Wible B C, Mitchell S. Doxycycline sclerotherapy of an intraosseous femoral lymphatic malformation: case report and literature review.  J Vasc Interv Radiol. 2009;  20 660-663
• 133 Cho S K, Do Y S, Kim D I et al.. Peripheral arteriovenous malformations with a dominant outflow vein: results of ethanol embolization.  Korean J Radiol. 2008;  9 258-267
• 134 Do Y S, Park K B, Cho S K. How do we treat arteriovenous malformations (tips and tricks)?.  Tech Vasc Interv Radiol. 2007;  10 291-298
• 135 Houdart E, Gobin Y P, Casasco A, Aymard A, Herbreteau D, Merland J J. A proposed angiographic classification of intracranial arteriovenous fistulae and malformations.  Neuroradiology. 1993;  35 381-385
• 136 Lee B B, Do Y S, Yakes W, Kim D I, Mattassi R, Hyon W S. Management of arteriovenous malformations: a multidisciplinary approach.  J Vasc Surg. 2004;  39 590-600
• 137 Jackson J E, Mansfield A O, Allison D J. Treatment of high-flow vascular malformations by venous embolization aided by flow occlusion techniques.  Cardiovasc Intervent Radiol. 1996;  19 323-328
• 138 Rao V R, Mandalam K R, Gupta A K, Kumar S, Joseph S. Dissolution of isobutyl 2-cyanoacrylate on long-term follow-up.  AJNR Am J Neuroradiol. 1989;  10 135-141
• 139 Tan K T, Simons M E, Rajan D K, Terbrugge K. Peripheral high-flow arteriovenous vascular malformations: a single-center experience.  J Vasc Interv Radiol. 2004;  15 1071-1080
• 140 White Jr R I, Pollak J, Persing J, Henderson K J, Thomson J G, Burdge C M. Long-term outcome of embolotherapy and surgery for high-flow extremity arteriovenous malformations.  J Vasc Interv Radiol. 2000;  11 1285-1295
• 141 Weber J. Techniques and results of therapeutic catheter embolization of congenital vascular defects.  Int Angiol. 1990;  9 214-223
• 142 Bae S, Do Y S, Shin S W et al.. Ethanol embolotherapy of pelvic arteriovenous malformations: an initial experience.  Korean J Radiol. 2008;  9 148-154
• 143 Mitsuzaki K, Yamashita Y, Utsunomiya D et al.. Balloon-occluded retrograde transvenous embolization of a pelvic arteriovenous malformation.  Cardiovasc Intervent Radiol. 1999;  22 518-520
• 144 Doppman J L, Pevsner P H. Embolization of arteriovenous malformations by direct percutaneous puncture.  AJR Am J Roentgenol. 1983;  140 773-778
• 145 Gomes A S. Embolization therapy of congenital arteriovenous malformations: use of alternate approaches.  Radiology. 1994;  190 191-198
• 146 Hyodoh H, Fujita A, Hyodoh K, Furuse M, Kamisawa O, Hareyama M. High-flow arteriovenous malformation of the lower extremity: ethanolamine oleate sclerotherapy.  Cardiovasc Intervent Radiol. 2001;  24 348-351
• 147 Pollak J S, White Jr R I. The use of cyanoacrylate adhesives in peripheral embolization.  J Vasc Interv Radiol. 2001;  12 907-913
• 148 Castaneda F, Goodwin S C, Swischuk J L et al.. Treatment of pelvic arteriovenous malformations with ethylene vinyl alcohol copolymer (Onyx).  J Vasc Interv Radiol. 2002;  13 513-516
• 149 Numan F, Omeroglu A, Kara B, Cantaşdemir M, Adaletli I, Kantarci F. Embolization of peripheral vascular malformations with ethylene vinyl alcohol copolymer (Onyx).  J Vasc Interv Radiol. 2004;  15 939-946
• 150 Taki W, Yonekawa Y, Iwata H, Uno A, Yamashita K, Amemiya H. A new liquid material for embolization of arteriovenous malformations.  AJNR Am J Neuroradiol. 1990;  11 163-168
• 151 Fayad L M, Hazirolan T, Carrino J A, Bluemke D A, Mitchell S. Venous malformations: MR imaging features that predict skin burns after percutaneous alcohol embolization procedures.  Skeletal Radiol. 2008;  37 895-901
• 152 Lee B B, Do Y S, Byun H S, Choo I W, Kim D I, Huh S H. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results.  J Vasc Surg. 2003;  37 533-538
• 153 Goyal M, Causer P A, Armstrong D. Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification.  Radiology. 2002;  223 639-644
• 154 Lee B B, Kim D I, Huh S et al.. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation.  J Vasc Surg. 2001;  33 764-772
• 155 Coetzee P F, Ionescu G O, Fourie P et al.. Results of intralesional bleomycin injection treatment for congenital vascular anomalies. Paper presented at: 15th Congress of the International Society for the Study of Vascular Anomalies 2004 Wellington, New Zealand;
• 156 Kim K H, Sung M W, Roh J L, Han M H. Sclerotherapy for congenital lesions in the head and neck.  Otolaryngol Head Neck Surg. 2004;  131 307-316
• 157 Yura J, Hashimoto T, Tsuruga N, Shibata K. Bleomycin treatment for cystic hygroma in children.  Nippon Geka Hokan. 1977;  46 607-614
• 158 van der Linden E, Pattynama P M, Heeres B C, de Jong S C, Hop W C, Kroft L J. Long-term patient satisfaction after percutaneous treatment of peripheral vascular malformations.  Radiology. 2009;  251 926-932
• 159 Yamaki T, Nozaki M, Sasaki K. Color duplex-guided sclerotherapy for the treatment of venous malformations.  Dermatol Surg. 2000;  26 323-328
• 160 Sanlialp I, Karnak I, Tanyel F C, Senocak M E, Büyükpamukçu N. Sclerotherapy for lymphangioma in children.  Int J Pediatr Otorhinolaryngol. 2003;  67 795-800
• 161 Enjolras O. Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations.  J Dermatol. 1997;  24 701-710
• 162 Vaidya S, Cooke D, Kogut M, Stratil P, Bittles M, Sidhu M. Imaging and percutaneous treatment of vascular anomalies.  Semin Intervent Radiol. 2008;  25 216-233